Digital When will “digital health” just become health? Despite the significant drop in funding in 2022, digital health is here to stay.
News Pear Tx files for bankruptcy, will seek to sell assets Boston-based Pear Therapeutics, one of the first digital therapeutics companies to secure FDA clearance and forge pharma partnerships, is bowing out.
News Poll finds just one fifth of doctors have prescribed a DTx A large, international survey of thousands of doctors has revealed that a majority are still not confident enough to prescribe
News Future Health report: Expert opinion on digital therapeutics Healthware Group has released the expert opinion report, ‘Digital therapeutics to enhance the care pathways for depression across the national health service: expert propo
News Digital health firm Pear considers future as cash dwindles Company looks at possible sale, merger or licensing deal after making big layoffs last year.
Digital DTx and the case for fit-for-purpose evidentiary standard DTx deliver evidence-based therapeutic interventions driven by high-quality software programs
News RFK Jr revives childhood vaccine task force HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
